Adjunctive topiramate in ultradian cycling bipolar disorder: case report with 3-year follow-up.
Karama S, Lal S
Resident in Psychiatry, Douglas Hospital Research Center, McGill University, 6875 LaSalle Blvd., Verdun, Que., Canada H4H 1R3.
A patient with a treatment-refractory bipolar disorder with ultradian cycling responded to adjunctive topiramate. Response was maintained during 3-year follow-up.
Published 3 July 2006 in Eur Psychiatry, 21(4): 280-1.
Full-text of this article is available online (may require subscription).
© 2004-2008 Bipolar Research Today. All Rights Reserved.
|